Marked differences in the prevalence of chloroquine resistance between urban and rural communities in Burkina Faso

Acta Tropica

Volumn 105, Issue 1, 2008, Pages 81-86

  Meissner, Peter E ^a   Mandi, Germain ^b   Mockenhaupt, Frank P ^c   Witte, Steffen ^a   Coulibaly, Boubacar ^b   Mansmann, Ulrich ^a,d   Frey, Claudia ^a   Merkle, Heiko ^a   Burhenne, Juergen ^a   Walter Sack, Ingeborg ^a   Müller, Olaf ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CENTRE DE RECHERCHE EN SANTÉ DE NOUNA   (Burkina Faso)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chloroquine resistance; Drug pressure; Pfcrt T76; Urban; Village

Indexed keywords

CHLOROQUINE; METHYLENE BLUE;

CHILD; DRUG RESISTANCE; RURAL AREA; URBAN AREA;

ANTIBIOTIC RESISTANCE; ARTICLE; BURKINA FASO; CHILD; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; GENE; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; OUTCOME ASSESSMENT; PARASITE PREVALENCE; PLASMODIUM FALCIPARUM; PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER GENE; RURAL POPULATION; URBAN POPULATION;

ANIMALS; BURKINA FASO; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; HUMANS; INFANT; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; PLASMODIUM FALCIPARUM; POINT MUTATION; PROTOZOAN PROTEINS; RURAL POPULATION; TREATMENT OUTCOME; URBAN POPULATION;

AFRICA; BURKINA FASO; SUB-SAHARAN AFRICA; WEST AFRICA;

PLASMODIUM FALCIPARUM;

EID: 37249085776     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2007.07.014     Document Type: Article

References (27)

1. Abdel-Muhsin A.M., Ranford-Cartwright L.C., Medani A.R., Ahmed S., Suleiman S., Khan B., Hunt P., Walliker D., and Babiker H.A. Detection of mutations in the Plasmodium falciparum dihydrofolate reductase (dhfr) gene by dot-blot hybridization. Am. J. Trop. Med. Hyg. 67 (2002) 24-27
2. Abdel-Aziz I.Z., Oster N., Stich A., Coulibaly B., Guigemde W.A., Wickert H., Andrews K.T., Kouyaté B., and Lanzer M. Association of Plasmodium falciparum isolates encoding the P. falciparum chloroquine resistance transporter gene T76 polymorphism with anemia and splenomegaly, but not with multiple infections. Am. J. Trop. Med. Hyg. 72 (2005) 252-255
3. Arav-Boger R., and Shapiro T.A. Molecular mechanisms of resistance in antimalarial chemotherapy. The unmet challenge. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 565-585
4. Ariey F., Fandeur T., Durand R., Randrianarivelojosia M., Jambou R., Legrand E., Ekala M.T., Bouchier C., Cojean S., Duchemin J.B., Robert V., Le Bras J., and Mercereau-Puijalon O. Invasion of Africa by a single pfcrt allele of South East Asian type. Malaria J. 5 (2006) 34
5. Djimde A., Doumbo O.K., Cortese J.F., Kayentao K., Doumbo S., Diourte Y., Dicko A., Su X.Z., Nomura T., Fidock D.A., Wellems T.E., Plowe C.V., and Coulibaly D. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344 (2001) 257-263
6. Fidock D.A., Nomura T., Talley A.K., Cooper R.A., Dzekunov S.M., Ferdig M.T., Ursos L.M., Sidhu A.B., Naude B., Deitsch K.W., Su X.Z., Wootton J.C., Roepe P.D., and Wellems T.E. Mutations in the P. falciparum digestive vacuole transmembrane protein pfcrt and evidence for their role in chloroquine resistance. Mol. Cell. 6 (2000) 861-871
7. Guiguemde T.R., Aouba A., Ouedraogo J.B., and Lamizana L. Ten-year surveillance of drug-resistant malaria in Burkina Faso (1982-1991). Am. J. Trop. Med. Hyg. 50 (1994) 699-704
8. Kouyaté B., Sié A., de Allegri M., and Müller O. The great failure of malaria control in Africa: a district perspective from Burkina Faso. Plos. Med. 4 (2007) e127
9. Mandi G., Witte S., Meissner P.E., Coulibaly B., Mansmann U., Rengelshausen J., Schiek W., Jahn A., Sanon M., Wüst K., Walter-Sack I., Mikus G., Burhenne J., Riedel K.D., Schirmer H., Kouyate B., and Müller O. Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso. Trop. Med. Int. Health 10 (2005) 32-38
10. Marks F., Evans J., Meyer C.G., Browne E.N., Flessner C., von Kalckreuth V., Eggelte T.A., Horstmann R.D., and May J. High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana. Antimicrob. Agents Chemother. 49 (2005) 1101-1105
11. Meissner P., Mandi G., Witte S., Coulibaly B., Mansmann U., Rengelshausen J., Schiek W., Jahn A., Sanon M., Tapsoba T., Walter-Sack I., Mikus G., Burhenne J., Riedel K.D., Schirmer H., Kouyate B., and Müller O. Safety of the combination of chloroquine and methylene blue in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso. Malaria J. 4 (2005) 46
12. Mockenhaupt F.P., May J., Eggelte T.A., Thies F.L., Ademowo O.G., Bienzle U., and Meyer C.G. Short report: high prevalence and imbalanced age distribution of the Plasmodium falciparum dihydrofolate reductase gene Asn108 mutation in an area of low pyrimethamine usage in Nigeria. Am. J. Trop. Med. Hyg. 61 (1999) 375-377
13. Mockenhaupt F.P., Ehrhardt S., Eggelte T.A., Agana-Nsiire P., Stollberg K., Mathieu A., Markert M., Otchwemah R.N., and Bienzle U. Chloroquine-treatment failure in northern Ghana: roles of pfcrt T76 and pfmdr1 Y86. Ann. Trop. Med. Parasitol. 99 (2005) 723-732
14. Müller O., Traoré C., Kouyaté B., and Becher H. Malaria morbidity, treatment seeking behaviour and mortality in a cohort of young children in rural Burkina Faso. Trop. Med. Int. Health 8 (2003) 290-296
15. Müller O., Traoré C., and Kouyaté B. Clinical efficacy of chloroquine in young children with uncomplicated malaria - a community based study in rural Burkina Faso. Trop. Med. Int. Health 8 (2003) 202-203
16. Müller O., Razum O., Traore C., and Kouyate B. Community effectiveness of chloroquine and traditional remedies in the treatment of young children with falciparum malaria in rural Burkina Faso. Malaria J. 3 (2004) 36
17. Plowe C.V., Djimde A., Wellems T.E., Diop S., Kouriba B., and Doumbo O.K. Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance. Am. J. Trop. Med. Hyg. 55 (1996) 467-471
18. Rengelshausen J., Burhenne J., Fröhlich M., Tayrouz Y., Singh S.K., Riedel K.D., Müller O., Hoppe-Tichy T., Haefeli W.E., Mikus G., and Walter-Sack I. Pharmacokinetic interaction of chloroquine and methylene-blue combination against malaria. Eur. J. Clin. Pharmacol. 60 (2004) 709-715
19. Sirima S.B., Tiono A.B., Konate A., Diarra A., Castelli F., Pinoges L., Mugittu K., Taylor W.R., and Olliaros P.L. Efficacy of artesunate plus chloroquine for the treatment of uncomplicated malaria in children in Burkina Faso: a double-blind, randomized, controlled trial. Trans. R. Soc. Trop. Med. Hyg. 97 (2003) 345-349
20. Talisuna A.O., Bloland P., and D'Alessandro U. History, dynamics, and public health importance of malaria parasite resistance. Clin. Microbiol. Rev. 17 (2004) 235-254
21. Tinto H., Zoungrana E.B., Coulibaly S.O., Ouedraogo J.B., Traoré M., Guiguemde T.R., Van Marck E., and D'Alessandro U. Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso Burkina Faso during a 3-year period 1998-2000. Trop. Med. Int. Health 7 (2002) 925-930
22. Traoré, C., 2003. Epidemiology of malaria in a holoendemic area of rural Burkina Faso. PhD thesis, Heidelberg University, Germany.
23. Trapé J.F., Pison G., Preziosi M.P., Enel C., Desgrees du Lou A., Delaunay V., Samb B., Lagarde E., Molez J.F., and Simondon F. Impact of chloroquine resistance on malaria mortality. C. R. Acad. Sci. III 321 (1998) 689-697
24. Trapé J.F. The public health impact of chloroquine resistance in Africa. Am. J. Trop. Med. Hyg. 64 (2001) 12-17
25. White N.J. Antimalarial drug resistance. J. Clin. Invest. 113 (2004) 1084-1092
26. WHO, 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. World Health Organization, Geneva, WHO/HTM/RBM/2003.50.
27. Yayon A., Cabantchik Z.I., and Ginsburg H. Identification of the acid compartment of Plasmodium falciparum human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 3 (1984) 2695-2700